ANI Pharmaceuticals | ANIP - Sales Revenues

Stock Price
75.02
Daily Change
0.85 1.15%
Monthly
-3.94%
Yearly
15.65%
Q1 Forecast
68.36

ANI Pharmaceuticals reported $247.06M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
ANI Pharmaceuticals USD 247.06M 19.25M Dec/2025
Assertio Holdings USD 29.2M 1.92M Sep/2024
Aurora Cannabis CAD 94.19M 3.82M Dec/2025
Canopy Growth CAD 66.68M 5.45M Sep/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Emergent BioSolutions USD 276.6M 6.1M Dec/2023
Heron Therapeutics USD 40.59M 2.38M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Knight Therapeutics CAD 121.55M 14.19M Sep/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Novartis USD 14.36B 478M Sep/2025
Perrigo USD 1.11B 70M Dec/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025